Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,272 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07455188Recruiting
Switching targeted therapies for advanced HER2-positive breast cancer
This trial tests whether switching between two targeted therapy combinations can help women with HER2-positive advanced breast cancer that has progressed after previous treatments. It aims to find a new effective option for people who have already tried one or two lines of therapy.
Zhejiang, HangzhouAges 18 years+ - NCT07454941Enrolling by invitation
AI-powered HER2 test study for bladder cancer patients
This study uses artificial intelligence to examine MRI scans and tissue samples to understand HER2 protein levels in urothelial carcinoma. It aims to improve how HER2 is assessed, which could guide future treatment decisions.
Beijing, Chaoyang DistrictAges 18 years+ - NCT07457333Enrolling by invitationPhase 1/Phase 2
Beta-sitosterol for recovery after a brain aneurysm bleed
This study tests a natural compound called beta-sitosterol (from Gastrodia elata) to see if it can help people recover better after a brain aneurysm bleed. You must have had your aneurysm treated within 48 hours and be in relatively stable condition.
Hangzhou, ZhejiangAges 18–75 - NCT07461233Recruiting
Gut Health and Synbiotics in Hemodialysis
This study tests whether taking a special mix of friendly bacteria and prebiotics (called synbiotics) can help improve gut health in people on hemodialysis. It may reduce inflammation and other complications related to kidney disease.
Taichung, Wuqi DistrictAges 18 years+ - NCT07458295Recruiting
Liposomal bupivacaine for pain after gynecologic cancer surgery
This trial tests whether a long-acting numbing medication (liposomal bupivacaine) injected into the abdominal wall can reduce pain after laparoscopic surgery for gynecologic cancer. If effective, it may help patients recover with less discomfort and fewer painkillers.
Beijing, Beijing MunicipalityAges 18–64 - NCT07458334Recruiting
Skincare benefits of a kaempferol face mask
This trial tests a face mask containing kaempferol, a natural plant compound, to see if it improves skin health. It may be a good option if you are a woman looking for a new skincare product.
Kaohsiung CityAges 25–60 - NCT07458256Recruiting
Liposomal bupivacaine for pain after laparoscopic surgery
This trial tests a long-acting painkiller injected during surgery to see if it reduces pain after keyhole (laparoscopic) procedures like gallbladder removal, hernia repair, or appendix removal. It may help you need fewer opioids and recover more comfortably.
Beijing, Beijing MunicipalityAges 18–64 - NCT07456488RecruitingPhase 2
Atropine eye drops for nearsighted children
This study tests if low-dose atropine eye drops can slow down worsening nearsightedness in children. Children in the study receive either the drops or no treatment, and their vision changes are tracked over time.
Karachi, SindhAges 4–16 - NCT07462065RecruitingPhase 4
Clomiphene with or without Pioglitazone for PCOS
This study compares two fertility treatments: clomiphene alone or clomiphene plus pioglitazone. It aims to see if adding pioglitazone improves ovarian stimulation in women with PCOS.
Islamabad, FederalAges 18–38 - NCT07457528RecruitingPhase 2
Chemo, radiation, and immune therapy before surgery for esophageal cancer
This trial tests a combination of chemotherapy, radiation, and two targeted drugs (serplulimab and nimotuzumab) given before surgery for a certain type of esophageal cancer. It aims to see if this approach can safely improve outcomes.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT07454343Recruiting
Observational study on Erdheim-Chester disease
This study collects information from patients with Erdheim-Chester disease (ECD) to better understand the condition and how it is treated. By looking at medical records, researchers hope to improve care for people with ECD.
Bethesda, MarylandAges 7 years+ - NCT07454421Enrolling by invitationPhase 1/Phase 2
Racecadotril for organ injury in sepsis patients
This trial tests if Racecadotril, a medication that may protect organs from damage, can help people with sepsis (a severe infection that affects the whole body). It is for patients who are in the hospital and have a certain level of organ injury.
Guanzhou, GuangdongAges 18–80 - NCT07458568Recruiting
ViBandz study for children with movement problems
This study tests a wearable device called ViBandz that gives gentle vibrations to help children with neurologic conditions move better. It is for children who are already scheduled to receive this type of vibration therapy as part of their regular care at Children's Mercy Hospital.
Kansas City, MissouriAges 6 months–17 years - NCT07460037Recruiting
Brain signal study for speech recovery after stroke or injury
This trial uses a special brain-mapping test called high-density ECoG to study how people who have lost speech due to stroke, brain tumor, or ALS can be helped by reading brain signals when they imagine speaking. It may lead to new devices that let people with severe speech problems communicate using only their thoughts.
Hangzhou, ZhejiangAges 20–80 - NCT07456111RecruitingPhase 4
Comparing two sedatives for colonoscopy with polyp removal
This trial compares two sedative medications, remimazolam and propofol, to see which works better and is safer for people having a colonoscopy to remove polyps. It could help choose a sedation option with fewer side effects.
ZagrebAges 18–60 - NCT06374589Recruiting
Closing the loop on oxygen use during high flow therapy
This trial tests a system that automatically adjusts oxygen levels for patients receiving high flow oxygen therapy. The goal is to see if it can keep oxygen levels in a safe range better than usual care.
IstanbulAges 18 years+ - NCT06305468Recruiting
Toxoplasmosis prognosis in ICU patients diagnosed by PCR
This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.
Paris, FranceAges 18–100 - NCT06478030Recruiting
Combined screening for stomach and bowel cancer
This study is testing a combined screening method for finding cancer in the stomach and intestines at an early stage. It is for people in Zhejiang Province who are willing to be screened and followed over time.
Jinhua, ZhejiangAges 40–74 - NCT06676267Recruiting
Laparoscopic surgery for gynecological and remote procedures
This trial tests a laparoscopic surgical system for gynecological and remote surgeries. It may help patients who need minimally invasive surgery and can follow the study plan.
Nantong, JiangsuAges 18–80 - NCT06643793RecruitingPhase 2
Irinotecan liposome combo for advanced colorectal cancer
This trial tests a new form of the chemotherapy drug irinotecan (called irinotecan liposome) combined with two other chemo drugs and a targeted therapy (bevacizumab) for people with advanced colorectal cancer that has already been treated with oxaliplatin. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Nanjing, JiangsuAges 18–75 - NCT06696677Recruiting
Measuring small bowel length in repeat weight-loss surgery
This study compares two ways to measure the length of your small intestine during a second weight-loss surgery. One method uses a 3D CT scan before surgery, and the other uses a special tool during surgery. The goal is to see which method is more accurate and safer.
Cairo, Old CairoAges 16–70 - NCT06685289RecruitingPhase 2
Donafenib and capecitabine after surgery for biliary cancer with high risk of return
This trial tests whether taking donafenib and capecitabine pills after surgery can help prevent biliary cancer from coming back in people who have a high risk of recurrence. It is for patients whose cancer was completely removed but had certain features that make recurrence more likely.
Nanjing, JiangsuAges 18–75 - NCT06707233RecruitingPhase 2
Y-90 radioembolization for large liver cancer (over 7 cm)
This trial tests a treatment called Y-90 radioembolization (SIRT) for people with liver cancer that is too large to be removed surgically. The treatment delivers tiny radioactive beads directly to the tumor through the liver's blood supply, which may shrink the tumor and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT06796634Recruiting
Cold plasma for cancer in the abdomen
This trial tests whether a special cold gas (called cold atmospheric plasma) can help destroy cancer cells left in the abdomen after surgery. It's for people with certain cancers that have spread to the belly lining.
Ghent, East-FlandersAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,272 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.